Daptomycin activity against uncommonly isolated streptococcal and other Gram-positive species groups

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 12, 2013, Pages 6378-6380

  Sader, Helio S ^a   Flamm, Robert K ^a   Farrell, David J ^a   Jones, Ronald N ^a  

^a JMI LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAPTOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BROTH DILUTION; CORYNEBACTERIUM; DRUG ACTIVITY; DRUG EFFICACY; DRUG SAFETY; GRAM POSITIVE BACTERIUM; IN VITRO STUDY; LISTERIA MONOCYTOGENES; MICROCOCCUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS; STREPTOCOCCUS ANGINOSUS; STREPTOCOCCUS BOVIS; STREPTOCOCCUS DYSGALACTIAE; STREPTOCOCCUS GROUP G; STREPTOCOCCUS MITIS; STREPTOCOCCUS ORALIS; STREPTOCOCCUS PARASANGUINIS;

ANTI-BACTERIAL AGENTS; CORYNEBACTERIUM; DAPTOMYCIN; GRAM-NEGATIVE BACTERIA; LISTERIA MONOCYTOGENES; MICROBIAL SENSITIVITY TESTS; STREPTOCOCCUS; STREPTOCOCCUS BOVIS;

EID: 84887456023     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01906-13     Document Type: Article

References (12)

1. Cubist Pharmaceuticals, Inc. 2012. Cubicin package insert. Cubist Pharmaceuticals, Inc., Lexington, MA. http://www.cubicin.com/pdf/ PrescribingInformation.pdf.
2. Kullar R, Davis SL, Levine DP, Zhao JJ, Crank CW, Segreti J, Sakoulas G, Cosgrove SE, Rybak MJ. 2011. High-dose daptomycin for treatment of complicated Gram-positive infections: a large, multicenter, retrospective study. Pharmacotherapy 31:527-536.
3. Levine DP. 2008. Clinical experience with daptomycin: bacteraemia and endocarditis. J. Antimicrob. Chemother. 62(Suppl 3):iii35-iii39.
4. Sader HS, Jones RN. 2012. Antimicrobial activity of daptomycin in comparison to glycopeptides and other antimicrobials when tested against numerous species of coagulase-negative Staphylococcus. Diagn. Microbiol. Infect. Dis. 73:212-214.
5. Sader HS, Flamm RK, Jones RN. 2013. Antimicrobial activity of daptomycin tested against Gram-positive pathogens collected in Europe, Latin America, and selected countries in the Asia-Pacific region (2011). Diagn. Microbiol. Infect. Dis. 75:417-422.
6. Clinical and Laboratory Standards Institute. 2012. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard M07-A9-9th edition. Clinical and Laboratory Standards Institute, Wayne, PA.
7. Clinical and Laboratory Standards Institute. 2013. Performance standards for antimicrobial susceptibility testing: 23rd informational supplement. M100-S23. Clinical and Laboratory Standards Institute, Wayne, PA.
8. Bruckner L, Gigliotti F. 2006. Viridans group streptococcal infections among children with cancer and the importance of emerging antibiotic resistance. Semin. Pediatr. Infect. Dis. 17:153-160.
9. Al-Charrakh AH, Al-Khafaji JK, Al-Rubaye RH. 2011. Prevalence of beta-hemolytic groups C and F streptococci in patients with acute pharyngitis. N. Am. J. Med. Sci. 3:129-136.
10. Bernard K. 2012. The genus Corynebacterium and other medically relevant coryneform-like bacteria. J. Clin. Microbiol. 50:3152-3158.
11. Miltiadous G, Elisaf M. 2011. Native valve endocarditis due to Micrococcus luteus: a case report and review of the literature. J. Med. Case Rep. 5:251.
12. Doganay M. 2003. Listeriosis: clinical presentation. FEMS Immunol. Med. Microbiol. 35:173-175.